Suppr超能文献

俯卧位持续时间对急性呼吸窘迫综合征患者接受静脉-静脉体外膜肺氧合治疗结局的影响:一项荟萃分析。

Impact of prone positioning duration on the outcome of patients receiving venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: A meta-analysis.

作者信息

Huai Jiaping, Ye Xiaohua

机构信息

Department of Critical Care Medicine, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang, 321000, China.

Department of Gastroenterology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang, 321000, China.

出版信息

Heliyon. 2022 Dec;8(12):e12320. doi: 10.1016/j.heliyon.2022.e12320. Epub 2022 Dec 20.

Abstract

PURPOSE

Research has shown that prone positioning (PP) improves the survival of patients receiving venovenous extracorporeal membrane oxygenation (V-V ECMO) for acute respiratory distress syndrome (ARDS). However, the reported impact of PP duration on the outcome of V-V ECMO patients with ARDS varies across studies.

METHODS

A meta-analysis approach was used to identify studies that investigated the impact of PP duration on the outcome of ARDS patients who were treated with V-V ECMO; the following databases were used: MEDLINE, Embase, Wanfang, and the China National Knowledge Infrastructure. The primary outcome was cumulative survival. Secondary outcomes were length of stay in an intensive care unit, exchange of arterial blood gases, and adverse events.

RESULTS

A total of 8 studies were included in the final meta-analysis. Patients with longer duration of PP (≥12 h) had a longer survival period (risk ratio: 1.24; 95% confidence interval: 1.00, 1.54]) than those with PP < 12 h. There was no evidence of publication bias across the studies.

CONCLUSION

Our results imply that a longer duration of PP ≥ 12 h might improve the outcome of patients with ARDS who receive V-V ECMO therapy.

摘要

目的

研究表明,俯卧位通气(PP)可提高急性呼吸窘迫综合征(ARDS)患者接受静脉-静脉体外膜肺氧合(V-V ECMO)治疗的生存率。然而,不同研究报道的PP持续时间对ARDS患者V-V ECMO治疗结局的影响各不相同。

方法

采用荟萃分析方法,检索研究PP持续时间对接受V-V ECMO治疗的ARDS患者结局影响的研究;使用以下数据库:MEDLINE、Embase、万方和中国知网。主要结局为累积生存率。次要结局为重症监护病房住院时间、动脉血气交换和不良事件。

结果

最终的荟萃分析共纳入8项研究。PP持续时间较长(≥12小时)的患者比PP<12小时的患者生存期更长(风险比:1.24;95%置信区间:1.00,1.54)。各项研究均无发表偏倚的证据。

结论

我们的结果表明,PP持续时间≥12小时可能改善接受V-V ECMO治疗的ARDS患者的结局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e8/9803780/ebd8b92f4751/gr1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验